US-based generic pharmaceutical manufacturer and supplier Padagis announced on Wednesday that the company's over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has obtained an extended shelf-life of 36 months.

Padagis' Naloxone HCl Nasal Spray is an original prescription-strength medication designed to rapidly reverse the effects of a life-threatening opioid overdose.

The three-year expiration will apply to newly manufactured medicine that is planned to be released by Padagis as early as late second quarter of this year. Padagis advised customers and consumers to follow the expiration date printed on the product packaging.